Medical News on Cancer
Discovery Of Molecule In Immune System That Could Help Treat Melanoma
Jul 10, 2012
Researchers from Brigham and Women's Hospital (BWH) have made a groundbreaking discovery that will shape the future of melanoma therapy. The team, led by Thomas S. Kupper, MD, chair of the BWH Department of Dermatology, and Rahul Purwar, PhD, found that high expression of a cell-signaling molecule, known as interleukin-9, in immune cells inhibits melanoma growth... Read More
For Production Of Early T-Cell Progenitors, Transcription Factor Lyl-1 Is Critical
Jul 10, 2012
A transcription factor called Lyl-1 is necessary for production of the earliest cells that can become T-cells, critical cells born in the thymus that coordinate the immune response to cancer or infections, said a consortium of researchers led by those from Baylor College of Medicine in a report in the journal Nature Immunology... Read More
Genetic Test To Decide Whether Erbitux Works For Colon Cancer Patients Approved By FDA
Jul 09, 2012
Up until now, some colorectal cancer (CRC) patients and their doctors had no way of determining whether the drug Erbitux (cetuximab) would be a helpful treatment based on the absence of a KRAS gene mutation. On July 6, 2012, the United States Food and Drug Administration (FDA) approved the first genetic test to help doctors decide which colon cancer patients might respond well to cetuximab... Read More
Sanofi Cancels Heparin Substitute Semuloparin
Jul 09, 2012
The experimental drug Semuloparin which acts to prevent blood clots and was considered as an alternative to standard heparins, has been withdrawn by it's European based manufacturer Sanofi. They have announced today that they will no longer be seeking marketing approval for the experimental medication... Read More
New Guideline Provides Evidence-Based Recommendations On Use Of Sentinel Lymph Node Biopsy For Melanoma Staging In The United States
Jul 09, 2012
The American Society of Clinical Oncology (ASCO) and the Society for Surgical Oncology (SSO) have issued their first evidence-based clinical practice guideline on the use of sentinel lymph node biopsy (SLNB) to stage patients with newly diagnosed melanoma... Read More
HPV Vaccine Reduces Spread Even In Unvaccinated
Jul 09, 2012
The Cincinnati Children's Hospital Medical Center published a study in Pediatrics today showing that non immunized teens were showing a lower infection rate of the human papillomavirus. Usually, in large populations, vaccination tends to reduce the spread of a disease even in those without the vaccine... Read More
Discovery Has Potential To Prevent Metastasis In Prostate And Other Cancers
Jul 09, 2012
Prostate cancer doesn't kill in the prostate - it's the disease's metastasis to other tissues that can be fatal... Read More
Researchers Use Zebrafish To Provide Insights Into Causes And Treatment Of Human Diseases
Jul 09, 2012
Zebrafish, popular as aquarium fish, now have an important place in research labs as a model organism for studying human diseases... Read More
Leukemia And Myelodysplasia Patients May Benefit From Rabbit Antibodies
Jul 09, 2012
Researchers at Virginia Commonwealth University (VCU) Massey Cancer Center's Bone Marrow Transplant Program have demonstrated that the use of antibodies derived from rabbits can improve the survival and relapse outcomes of leukemia and myelodysplasia patients receiving a stem cell transplant from an unrelated donor... Read More
Molecule Discovered That Starves Lung Cancer And Improves Ventilator Recovery
Jul 09, 2012
A new research report published online in the FASEB Journal reveals a connection among sugar, cancer, and dependence on breathing machines - microRNA-320a. In the report, Stanford scientists show that the molecule microRNA-320a is responsible for helping control glycolysis... Read More
Previous Page Next Page